Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Vicarious Surgical Inc.
Report date July 13, 2022 · Filed July 15, 2022
Section 16 reporting ended · disclosed 2022-07-15. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A common stock, par value $0.0001 per shareSEC Table I · non-derivative | IndirectSee Footnote | 0 |
Reported balance
After 2022-07-13 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2022-07-13 · Other · Disposed 8,535,000 · Balance 0 F1: D8 Sponsor LLC was the record holder of the securities reported herein. David Chu is one of the two managers of D8 Sponsor LLC and shared voting and investment discretion with respect to the shares of Class A common stock held of record by D8 Sponsor LLC. Mr. Chu disclaimed any beneficial ownership of the securities held by D8 Sponsor LLC other than to the extent of any pecuniary interest he may have therein, directly or indirectly. D8 Sponsor LLC distributed 100% of the issued and outstanding shares of Class A common stock of the Issuer held by it to its members in accordance with the terms of its limited liability company agreement. F3: Under Rule 16a-13 promulgated under the Securities Exchange Act of 1934, as a change in form of beneficial ownership, the reported distribution by D8 Sponsor LLC to its members, and the reported acquisition by Mr. Chu from D8 Sponsor LLC, were exempt from Section 16 of the Securities Exchange Act of 1934. |
| Class A common stock, par value $0.0001 per shareSEC Table I · non-derivative | Direct | 815,446 |
Reported balance
After 2022-07-13 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2022-07-13 · Other · Acquired 815,446 · Balance 815,446 F2: D8 Sponsor LLC distributed 815,446 shares of Class A common stock of the Issuer to Mr. Chu in his capacity as a member of D8 Sponsor LLC. Mr. Chu is not a director, officer or 10% Owner. Accordingly, he is no longer subject to Section 16 of the Securities Exchange Act of 1934. F3: Under Rule 16a-13 promulgated under the Securities Exchange Act of 1934, as a change in form of beneficial ownership, the reported distribution by D8 Sponsor LLC to its members, and the reported acquisition by Mr. Chu from D8 Sponsor LLC, were exempt from Section 16 of the Securities Exchange Act of 1934. |
Filing footnotes · ownership attribution and instrument terms
F1: D8 Sponsor LLC was the record holder of the securities reported herein. David Chu is one of the two managers of D8 Sponsor LLC and shared voting and investment discretion with respect to the shares of Class A common stock held of record by D8 Sponsor LLC. Mr. Chu disclaimed any beneficial ownership of the securities held by D8 Sponsor LLC other than to the extent of any pecuniary interest he may have therein, directly or indirectly. D8 Sponsor LLC distributed 100% of the issued and outstanding shares of Class A common stock of the Issuer held by it to its members in accordance with the terms of its limited liability company agreement.
F2: D8 Sponsor LLC distributed 815,446 shares of Class A common stock of the Issuer to Mr. Chu in his capacity as a member of D8 Sponsor LLC. Mr. Chu is not a director, officer or 10% Owner. Accordingly, he is no longer subject to Section 16 of the Securities Exchange Act of 1934.
F3: Under Rule 16a-13 promulgated under the Securities Exchange Act of 1934, as a change in form of beneficial ownership, the reported distribution by D8 Sponsor LLC to its members, and the reported acquisition by Mr. Chu from D8 Sponsor LLC, were exempt from Section 16 of the Securities Exchange Act of 1934.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 13, 2022 Filed Jul 15, 2022 16:17 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | OtherClass A common stock, par value $0.0001 per share | 815,446 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-22-039658 · ownership.xml · nonDerivative · entry 2 CHU DAVID · CIK 0001199554 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 815,446 F2 · kind: D8 Sponsor LLC distributed 815,446 shares of Class A common stock of the Issuer to Mr. Chu in his capacity as a member of D8 Sponsor LLC. Mr. Chu is not a director, officer or 10% Owner. Accordingly, he is no longer subject to Section 16 of the Securities Exchange Act of 1934. F3 · kind: Under Rule 16a-13 promulgated under the Securities Exchange Act of 1934, as a change in form of beneficial ownership, the reported distribution by D8 Sponsor LLC to its members, and the reported acquisition by Mr. Chu from D8 Sponsor LLC, were exempt from Section 16 of the Securities Exchange Act of 1934. F2 · price: D8 Sponsor LLC distributed 815,446 shares of Class A common stock of the Issuer to Mr. Chu in his capacity as a member of D8 Sponsor LLC. Mr. Chu is not a director, officer or 10% Owner. Accordingly, he is no longer subject to Section 16 of the Securities Exchange Act of 1934. F2 · balance_after: D8 Sponsor LLC distributed 815,446 shares of Class A common stock of the Issuer to Mr. Chu in his capacity as a member of D8 Sponsor LLC. Mr. Chu is not a director, officer or 10% Owner. Accordingly, he is no longer subject to Section 16 of the Securities Exchange Act of 1934. Read SEC document |
| July 13, 2022 Filed Jul 15, 2022 16:17 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | OtherClass A common stock, par value $0.0001 per share | 8,535,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-22-039658 · ownership.xml · nonDerivative · entry 1 CHU DAVID · CIK 0001199554 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 F1 · kind: D8 Sponsor LLC was the record holder of the securities reported herein. David Chu is one of the two managers of D8 Sponsor LLC and shared voting and investment discretion with respect to the shares of Class A common stock held of record by D8 Sponsor LLC. Mr. Chu disclaimed any beneficial ownership of the securities held by D8 Sponsor LLC other than to the extent of any pecuniary interest he may have therein, directly or indirectly. D8 Sponsor LLC distributed 100% of the issued and outstanding shares of Class A common stock of the Issuer held by it to its members in accordance with the terms of its limited liability company agreement. F3 · kind: Under Rule 16a-13 promulgated under the Securities Exchange Act of 1934, as a change in form of beneficial ownership, the reported distribution by D8 Sponsor LLC to its members, and the reported acquisition by Mr. Chu from D8 Sponsor LLC, were exempt from Section 16 of the Securities Exchange Act of 1934. F1 · price: D8 Sponsor LLC was the record holder of the securities reported herein. David Chu is one of the two managers of D8 Sponsor LLC and shared voting and investment discretion with respect to the shares of Class A common stock held of record by D8 Sponsor LLC. Mr. Chu disclaimed any beneficial ownership of the securities held by D8 Sponsor LLC other than to the extent of any pecuniary interest he may have therein, directly or indirectly. D8 Sponsor LLC distributed 100% of the issued and outstanding shares of Class A common stock of the Issuer held by it to its members in accordance with the terms of its limited liability company agreement. F1 · balance_after: D8 Sponsor LLC was the record holder of the securities reported herein. David Chu is one of the two managers of D8 Sponsor LLC and shared voting and investment discretion with respect to the shares of Class A common stock held of record by D8 Sponsor LLC. Mr. Chu disclaimed any beneficial ownership of the securities held by D8 Sponsor LLC other than to the extent of any pecuniary interest he may have therein, directly or indirectly. D8 Sponsor LLC distributed 100% of the issued and outstanding shares of Class A common stock of the Issuer held by it to its members in accordance with the terms of its limited liability company agreement. F1 · ownership.nature: D8 Sponsor LLC was the record holder of the securities reported herein. David Chu is one of the two managers of D8 Sponsor LLC and shared voting and investment discretion with respect to the shares of Class A common stock held of record by D8 Sponsor LLC. Mr. Chu disclaimed any beneficial ownership of the securities held by D8 Sponsor LLC other than to the extent of any pecuniary interest he may have therein, directly or indirectly. D8 Sponsor LLC distributed 100% of the issued and outstanding shares of Class A common stock of the Issuer held by it to its members in accordance with the terms of its limited liability company agreement. Read SEC document |
| September 17, 2021 Filed Sep 21, 2021 21:00 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | Exercise / conversionClass B ordinary shares, par value $0.0001 per share · Derivative | 8,535,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-21-049215 · ownership.xml · derivative · entry 2 D8 Sponsor LLC · CIK 0001813880 · Director · 10% owner · Director by Deputization CHU DAVID · CIK 0001199554 · Director Tang Donald F · CIK 0001817370 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A ordinary shares · 8,535,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: In connection with the closing (the "Closing") of the business combination (the "Business Combination") between the Issuer (which was formerly known as D8 Holdings Corp. or "D8") and Vicarious Surgical Operating Co. (f/k/a Vicarious Surgical Inc.), among other things, (i) each of the then issued and outstanding Class B ordinary shares of D8 converted into Class A ordinary shares of D8 on a one-for-one basis as described under the heading "Description of Securities" in the Issuer's Registration Statement on Form S-1 (File No. 333-239503), (ii) D8 migrated to and domesticated as a Delaware corporation in accordance with Section 388 of the Delaware General Corporation Law, as amended, and the Cayman Islands Companies Act (As Revised) (the "Domestication") and (iii) each of the issued and outstanding Class A ordinary shares of D8 converted into shares of the Issuer's (after the Domestication) Class A common stock. F1 · kind: In connection with the closing (the "Closing") of the business combination (the "Business Combination") between the Issuer (which was formerly known as D8 Holdings Corp. or "D8") and Vicarious Surgical Operating Co. (f/k/a Vicarious Surgical Inc.), among other things, (i) each of the then issued and outstanding Class B ordinary shares of D8 converted into Class A ordinary shares of D8 on a one-for-one basis as described under the heading "Description of Securities" in the Issuer's Registration Statement on Form S-1 (File No. 333-239503), (ii) D8 migrated to and domesticated as a Delaware corporation in accordance with Section 388 of the Delaware General Corporation Law, as amended, and the Cayman Islands Companies Act (As Revised) (the "Domestication") and (iii) each of the issued and outstanding Class A ordinary shares of D8 converted into shares of the Issuer's (after the Domestication) Class A common stock. F1 · derivative.exercise_date: In connection with the closing (the "Closing") of the business combination (the "Business Combination") between the Issuer (which was formerly known as D8 Holdings Corp. or "D8") and Vicarious Surgical Operating Co. (f/k/a Vicarious Surgical Inc.), among other things, (i) each of the then issued and outstanding Class B ordinary shares of D8 converted into Class A ordinary shares of D8 on a one-for-one basis as described under the heading "Description of Securities" in the Issuer's Registration Statement on Form S-1 (File No. 333-239503), (ii) D8 migrated to and domesticated as a Delaware corporation in accordance with Section 388 of the Delaware General Corporation Law, as amended, and the Cayman Islands Companies Act (As Revised) (the "Domestication") and (iii) each of the issued and outstanding Class A ordinary shares of D8 converted into shares of the Issuer's (after the Domestication) Class A common stock. F1 · derivative.expiration_date: In connection with the closing (the "Closing") of the business combination (the "Business Combination") between the Issuer (which was formerly known as D8 Holdings Corp. or "D8") and Vicarious Surgical Operating Co. (f/k/a Vicarious Surgical Inc.), among other things, (i) each of the then issued and outstanding Class B ordinary shares of D8 converted into Class A ordinary shares of D8 on a one-for-one basis as described under the heading "Description of Securities" in the Issuer's Registration Statement on Form S-1 (File No. 333-239503), (ii) D8 migrated to and domesticated as a Delaware corporation in accordance with Section 388 of the Delaware General Corporation Law, as amended, and the Cayman Islands Companies Act (As Revised) (the "Domestication") and (iii) each of the issued and outstanding Class A ordinary shares of D8 converted into shares of the Issuer's (after the Domestication) Class A common stock. Read SEC document |
| September 17, 2021 Filed Sep 21, 2021 21:00 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | Exercise / conversionClass A common stock, par value $0.0001 per share | 8,535,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-21-049215 · ownership.xml · nonDerivative · entry 1 D8 Sponsor LLC · CIK 0001813880 · Director · 10% owner · Director by Deputization CHU DAVID · CIK 0001199554 · Director Tang Donald F · CIK 0001817370 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,535,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: In connection with the closing (the "Closing") of the business combination (the "Business Combination") between the Issuer (which was formerly known as D8 Holdings Corp. or "D8") and Vicarious Surgical Operating Co. (f/k/a Vicarious Surgical Inc.), among other things, (i) each of the then issued and outstanding Class B ordinary shares of D8 converted into Class A ordinary shares of D8 on a one-for-one basis as described under the heading "Description of Securities" in the Issuer's Registration Statement on Form S-1 (File No. 333-239503), (ii) D8 migrated to and domesticated as a Delaware corporation in accordance with Section 388 of the Delaware General Corporation Law, as amended, and the Cayman Islands Companies Act (As Revised) (the "Domestication") and (iii) each of the issued and outstanding Class A ordinary shares of D8 converted into shares of the Issuer's (after the Domestication) Class A common stock. F1 · price: In connection with the closing (the "Closing") of the business combination (the "Business Combination") between the Issuer (which was formerly known as D8 Holdings Corp. or "D8") and Vicarious Surgical Operating Co. (f/k/a Vicarious Surgical Inc.), among other things, (i) each of the then issued and outstanding Class B ordinary shares of D8 converted into Class A ordinary shares of D8 on a one-for-one basis as described under the heading "Description of Securities" in the Issuer's Registration Statement on Form S-1 (File No. 333-239503), (ii) D8 migrated to and domesticated as a Delaware corporation in accordance with Section 388 of the Delaware General Corporation Law, as amended, and the Cayman Islands Companies Act (As Revised) (the "Domestication") and (iii) each of the issued and outstanding Class A ordinary shares of D8 converted into shares of the Issuer's (after the Domestication) Class A common stock. F2 · balance_after: D8 Sponsor LLC is the record holder of the securities reported herein. David Chu and Donald Tang are the managers of D8 Sponsor LLC and share voting and investment discretion with respect to the shares of Class A common stock held of record by D8 Sponsor LLC. Each of the Messrs. Chu and Tang disclaims any beneficial ownership of the securities held by D8 Sponsor LLC other than to the extent of any pecuniary interest he may have therein, directly or indirectly. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.